CPT code 27049 represents an extensive surgical excision of a suspected malignant soft-tissue tumor in the pelvis or hip, removing the lesion and surrounding tissue when the combined tumor and margin diameter is under 5 cm. This oncologic procedure is clinically significant because it addresses limb- and function-preserving cancer management in anatomically complex regions where margin status and tissue preservation are critical. Nationally, accurate coding for these procedures affects surgical quality reporting, claims adjudication, and resource utilization for complex surgical oncology care.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context and service setting for 27049, followed by benchmarks and policy-relevant information affecting coverage and claims processing. The content outlines typical service lines and billing considerations, highlights common clinical scenarios for use of the code, and points to areas where payers and providers commonly align or differ on authorization and documentation requirements. Data not available in the input is noted where applicable, and the publication focuses on nationally relevant implications for coding, billing, and clinical documentation.